v3 Template
S

Sparian Biosciences, Inc.

Bio-pharmaceutical ~300 employees
Founded
--
Employees (Est.)
~300
15 leaders known
Total Funding
$38.5M
Funding Rounds
2
Last Funding
2024-11-14

About Sparian Biosciences, Inc.

Sparian Biosciences is a clinical stage bio-pharmaceutical company dedicated to discovering and developing new therapies targeting the central nervous system (CNS).

Products & Services

CNS Therapies:Focused on discovering and developing novel drugs for the central nervous system.

Specialties

Central Nervous System (CNS) Therapies Drug Discovery and Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 19500000
MR: -
FA: 19.5 million
FAN: 19500000
D: 2024-11-14
FD: 2024-11-14
1 investors
2 RT: Grant
T: -
FT: Grant
A: 19000000
MR: -
FA: 19 million
FAN: 19000000
D: 2023-08-08
FD: 2023-08-08
1 investors
Grant Latest
2024-11-14
$19.5M
1 investor (Pro only)
Grant 2023-08-08
$19.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jeff Reich

Co-Founder

A

Annie Pasternak

Chief Operating Officer

A

Alberto Bianchinotti

Chief Financial Officer

V

Vilomi Tringuk

VP of Program and Corporate Strategy

C

Christopher Verbicky

head of manufacturing and development

J

Judy Ashworth

Clinical

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

Sparian Biosciences, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Bio-pharmaceutical
Company Size
~300 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro